Home Institutions Mayo Clinic clinical trials Institution Directory
Clinical trials at Mayo Clinic Sites in Phoenix & Scottsdale, AZ
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:25 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
610
Current sort
Recently updated
Campus scope
Mayo Clinic, Phoenix & Scottsdale, AZ
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 181–192 of 610 matching trials with a site at Mayo Clinic, Phoenix & Scottsdale, AZ.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Breast Cancer, Metastatic
Interventions Evorpacept (ALX148), Trastuzumab, Paclitaxel, Capecitabine, Eribulin, Gemcitabine, Vinorelbine Drug
Lead sponsor ALX Oncology Inc. Industry
Eligibility 18 Years and older
Enrollment 120 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 28
States / cities Phoenix, Arizona • Tucson, Arizona • Duarte, California + 24 more
Conditions Multiple Myeloma
Interventions JNJ-79635322, Teclistamab Drug
Lead sponsor Janssen Research & Development, LLC Industry
Eligibility 18 Years and older
Enrollment 700 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2032
U.S. locations 41
States / cities Birmingham, Alabama • Phoenix, Arizona • Springdale, Arkansas + 38 more
Conditions Castration-Resistant Prostatic Cancer
Interventions Niraparib, Abiraterone Acetate, Prednisone, Placebo, New Formulation of Niraparib and Abiraterone Acetate (AA) Drug
Lead sponsor Janssen Research & Development, LLC Industry
Eligibility 18 Years and older · Male only
Enrollment 765 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2019 – 2027
U.S. locations 47
States / cities Homewood, Alabama • Phoenix, Arizona • Tucson, Arizona + 40 more
Conditions Focal Epilepsy, Generalized Seizure, Drug Refractory Epilepsy
Interventions UNEEG SubQ device, seizure forecasts, nasal diazepam, Preventative Medication (PM) Device · Drug
Lead sponsor Mayo Clinic Other
Eligibility 18 Years to 75 Years
Enrollment 12 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2029
U.S. locations 3
States / cities Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota
Conditions Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Locally Advanced Rectal Adenocarcinoma
Interventions Capecitabine, 5-fluorouracil, Leucovorin calcium, Irinotecan, Oxaliplatin, Long Course Chemoradiotherapy, Computed Tomography, Magnetic Resonance Imaging, Sigmoidoscopy, biopsy Drug · Radiation · Procedure
Lead sponsor Alliance for Clinical Trials in Oncology Other
Eligibility 18 Years and older
Enrollment 760 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2037
U.S. locations 679
States / cities Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 483 more
Conditions Solid Tumors
Interventions IBI3020 Drug
Lead sponsor Fortvita Biologics (USA)Inc. Industry
Eligibility 18 Years to 75 Years
Enrollment 285 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 6
States / cities Phoenix, Arizona • Jacksonville, Florida • Rochester, Minnesota + 3 more
Conditions Bladder Cancer
Interventions TAR-200, Cetrelimab, BCG Vesiculture Drug · Biological
Lead sponsor Janssen Research & Development, LLC Industry
Eligibility 18 Years and older
Enrollment 1,135 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2029
U.S. locations 51
States / cities Scottsdale, Arizona • Little Rock, Arkansas • Long Beach, California + 42 more
Conditions Optic Neuritis, Myelitis, Myelitis, Transverse
Interventions High-dose corticosteroids (HDCS), High-dose corticosteroids (HDCS) and PLEX Drug
Lead sponsor Mayo Clinic Other
Eligibility 18 Years and older
Enrollment 382 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2031
U.S. locations 35
States / cities Birmingham, Alabama • Scottsdale, Arizona • Loma Linda, California + 27 more
Conditions Community-acquired Pneumonia
Interventions Doxycycline, Azithromycin Drug
Lead sponsor Mayo Clinic Other
Eligibility 18 Years and older
Enrollment 1,120 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2031
U.S. locations 5
States / cities Scottsdale, Arizona • Jacksonville, Florida • Mankato, Minnesota + 2 more
Conditions Migraine, Small Vessel Ischemic Disease, Multiple Sclerosis
Interventions Brain Neuroimaging Diagnostic Test
Lead sponsor Mayo Clinic Other
Eligibility 20 Years to 59 Years · Female only
Enrollment 50 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2028
U.S. locations 1
States / cities Phoenix, Arizona
Conditions Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Interventions BMS-986504, Pembrolizumab, Placebo, Cisplatin, Carboplatin, Pemetrexed, Paclitaxel, Nab-paclitaxel Drug · Other
Lead sponsor Bristol-Myers Squibb Industry
Eligibility 18 Years and older
Enrollment 590 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2031
U.S. locations 44
States / cities Anchorage, Alaska • Phoenix, Arizona • Tucson, Arizona + 38 more
Conditions Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8
Interventions Biospecimen Collection, Computed Tomography, Flotufolastat F-18 Gallium, Laparoscopic Radical Prostatectomy with Robotics, Pelvic Lymphadenectomy, Positron Emission Tomography, Relugolix Procedure · Other · Drug
Lead sponsor Mayo Clinic Other
Eligibility 18 Years and older · Male only
Enrollment 30 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2029
U.S. locations 1
States / cities Scottsdale, Arizona About this Mayo Clinic institution page
What this page lists ClinicalTrials.gov records that list Mayo Clinic in Phoenix & Scottsdale, AZ as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , trials led by Mayo Clinic at any site , browse by condition , or browse by U.S. city .